Oxidative Stress, Endothelial Dysfunction, and N -Acetylcysteine in Type 2 Diabetes Mellitus
Antioxidants & Redox Signaling · 2024-06 · 40 (16-18) · 968-989
DOI: 10.1089/ars.2023.0524 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 13.06.2024. Verfasst von Xin Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Ningbo No. 2 Hospital, Ningbo, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Acetylcysteine, Oxidative Stress, Reactive Oxygen Species. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NHLBI NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Significance: Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality globally. Endothelial dysfunction is closely associated with the development and progression of CVDs. Patients with diabetes mellitus (DM) especially type 2 DM (T2DM) exhibit a significant endothelial cell (EC) dysfunction with substantially increased risk for CVDs. Recent Advances: Excessive reactive oxygen species (ROS) and oxidative stress are important contributing factors to EC dysfunction and subsequent CVDs. ROS production is significantly increased in DM and is critically involved in the development of endothelial dysfunction in diabetic patients. In this review, efforts are made to discuss the role of excessive ROS and oxidative stress in the pathogenesis of endothelial dysfunction and the mechanisms for excessive ROS production and oxidative stress in T2DM. Critical Issues: Although studies with diabetic animal models have shown that targeting ROS with traditional antioxidant vitamins C and E or other antioxidant supplements provides promising beneficial effects on endothelial function, the cardiovascular outcomes of clinical studies with these antioxidant supplements have been inconsistent in diabetic patients. Future Directions: Preclinical and limited clinical data suggest that N -acetylcysteine (NAC) treatment may improve endothelial function in diabetic patients. However, well-designed clinical studies are needed to determine if NAC supplementation would effectively preserve endothelial function and improve the clinical outcomes of diabetic patients with reduced cardiovascular morbidity and mortality. With better understanding on the mechanisms of ROS generation and ROS-mediated endothelial damages/dysfunction, it is anticipated that new selective ROS-modulating agents and effective personalized strategies will be developed for the management of endothelial dysfunction in DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Ningbo No. 2 Hospital, Ningbo, China.
- Department of Respiratory Medicine, Ningbo No. 2 Hospital, Ningbo, China.
- Center for Precision Medicine, University of Missouri School of Medicine, Columbia, Missouri, USA.
- Division of Cardiovascular Medicine, Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, USA.
- Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Xin Li
Förderung
- NINDS NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Li, X., Zou, J., Lin, A., Chi, J., Hao, H., Chen, H., & Liu, Z. (2024). Oxidative Stress, Endothelial Dysfunction, and N -Acetylcysteine in Type 2 Diabetes Mellitus. Antioxidants & Redox Signaling, 40(16-18), 968-989. https://doi.org/10.1089/ars.2023.0524
Vancouver
Li X, Zou J, Lin A, Chi J, Hao H, Chen H, et al. Oxidative Stress, Endothelial Dysfunction, and N -Acetylcysteine in Type 2 Diabetes Mellitus. Antioxidants & Redox Signaling. 2024;40(16-18):968-989. doi:10.1089/ars.2023.0524
BibTeX
@article{Li2024,
author = {Li, Xin and Zou, Junyong and Lin, Aiping and Chi, Jingshu and Hao, Hong and Chen, Hong and Liu, Zhenguo},
title = {Oxidative Stress, Endothelial Dysfunction, and N -Acetylcysteine in Type 2 Diabetes Mellitus},
journal = {Antioxidants & Redox Signaling},
year = {2024},
volume = {40},
number = {16-18},
pages = {968--989},
doi = {10.1089/ars.2023.0524}
}
EUVIMED